Literature DB >> 34591267

Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women.

Imane Saif1, Amal Bouziyane1,2, Mustapha Benhessou1,3, Mohamed El Karroumi3, Moulay Mustapha Ennaji4.   

Abstract

BACKGROUND: The promoter region is a key element of gene expression regulation. In mammals, most of the genes present, at the level of their promoter, a large number of islands CpG. Age also is seen as another factor for developing breast cell cancer reaching the tumour stage. AIM: This study aimed to explore the hypermethylation of the BRCA1/2 promoter gene in women breast cancer and correlation with age and tumour stage.
MATERIALS AND METHODS: Fifty biopsies were derived from Moroccan women treated for breast carcinoma, the DNA extracted was treated by bisulphite and the targeted BRCA1/2 Amplicons were amplified by specific methylation primers (MSP).
RESULTS: The result shows that 62% of the samples were BRCA1 methylated in addition and negative result for BRCA2, these positive epigenetic factor were remarkable in women over 47 years and at the stage of malignant tumour.
CONCLUSION: These results show that half of the methylated samples are positive with a majority of over 47 years old, and confirms that age might be an additional factor for breast cancer development.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Age; BRCA1; BRCA2; Breast cancer; Cancer stage; Gene promoter; Methylation

Mesh:

Substances:

Year:  2021        PMID: 34591267     DOI: 10.1007/s11033-021-06705-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  6 in total

1.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

2.  BRCA1 gene mutation and loss of heterozygosity on chromosome 17q21 in primary prostate cancer.

Authors:  T Uchida; C Wang; T Sato; J Gao; R Takashima; A Irie; M Ohori; K Koshiba
Journal:  Int J Cancer       Date:  1999-02-19       Impact factor: 7.396

Review 3.  S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life.

Authors:  Jin Gao; Catherine M Cahill; Xudong Huang; Joshua L Roffman; Stefania Lamon-Fava; Maurizio Fava; David Mischoulon; Jack T Rogers
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

4.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

5.  Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.

Authors:  Christopher Grunseich; Isabel X Wang; Jason A Watts; Joshua T Burdick; Robert D Guber; Zhengwei Zhu; Alan Bruzel; Tyler Lanman; Kelian Chen; Alice B Schindler; Nancy Edwards; Abhik Ray-Chaudhury; Jianhua Yao; Tanya Lehky; Grzegorz Piszczek; Barbara Crain; Kenneth H Fischbeck; Vivian G Cheung
Journal:  Mol Cell       Date:  2018-01-27       Impact factor: 17.970

6.  BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia

Authors:  Wirsma Arif Harahap; Ikhwan R Sudji; Ricvan Dana Nindrea
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.